Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Cancer Conference Journal
Published in: International Cancer Conference Journal 4/2018

01-10-2018 | Correction

Publisher Correction to: Severe adverse events due to dihydropyrimidine dehydrogenase deficiency in a Japanese patient with colon cancer taking capecitabine: a case report

Authors: Mai Tsutsui, Seiichiro Yamamoto, Yusuke Yoshikawa, Ryo Nakanishi, Kiminori Takano, Koji Osumi, Tomotaka Akatsu, Kimiyasu Yoneyama, Motohito Nakagawa, Toshio Kanai

Published in: International Cancer Conference Journal | Issue 4/2018

Login to get access

Excerpt

The publisher regrets that in the original version of this article, unfortunately the word “phosphate” in Fig. 1 has been misspelt as “phosohate”. …
Metadata
Title
Publisher Correction to: Severe adverse events due to dihydropyrimidine dehydrogenase deficiency in a Japanese patient with colon cancer taking capecitabine: a case report
Authors
Mai Tsutsui
Seiichiro Yamamoto
Yusuke Yoshikawa
Ryo Nakanishi
Kiminori Takano
Koji Osumi
Tomotaka Akatsu
Kimiyasu Yoneyama
Motohito Nakagawa
Toshio Kanai
Publication date
01-10-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 4/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0336-z

Other articles of this Issue 4/2018

International Cancer Conference Journal 4/2018 Go to the issue

Case report

A case of uterine carcinosarcoma which was strongly suspected to have metastases to the psoas and gluteus muscles

Case report

A case of angiosarcomas which occurred in an adrenal gland and spleen synchronously

Video Article

Mesenteric excision for esophageal cancer surgery: based on the concept of mesotracheoesophagus

Case report

A young female case of primary renal carcinoid tumor mimicking fat-poor angiomyolipoma

Case report

Severe adverse events due to dihydropyrimidine dehydrogenase deficiency in a Japanese patient with colon cancer taking capecitabine: a case report

Case report

Reiter’s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits